<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The protein p73 is the first identified homolog of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene p53, but its function in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development has not been established </plain></SENT>
<SENT sid="1" pm="."><plain>Indeed, the results regarding the p73 implication in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> is still controversial </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: We investigated whether the p73 is implicated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, whether the p73 expression is related to prognosis and whether the p73 expression is correlated with p21-ras or p53 </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: We performed a comparative immunohistochemical analysis of p73, p53, and p21ras proteins in primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> with matched <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> from 204 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We correlated these expressions with clinicopathologic variables and we compared the different profiles between nonmucinous <z:mp ids='MP_0002038'>carcinoma</z:mp> and mucinous <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In this study, we did not find any correlation between p73 expression, sex, age, site, differentiation and stage </plain></SENT>
<SENT sid="6" pm="."><plain>Overexpression of p73 was significantly correlated with infiltrating growth pattern (P&lt;0.0001) and nonmucinous <z:mp ids='MP_0002038'>carcinoma</z:mp> (P&lt;0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, frequency and intensity of p73 expression were marquedly increased from <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (26%), to <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> (75%) and to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (97%) </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, expression of p73 was also correlated with shorter survival period </plain></SENT>
<SENT sid="9" pm="."><plain>The prognostic significance of p73 expression remained, even after adjustment for the clinical and pathologic variables </plain></SENT>
<SENT sid="10" pm="."><plain>The p73 expression was positively correlated only with p21ras expression (P&lt;0.0001) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0000001'>All</z:hpo> these findings prove that p73 expression should be considered as a valuable poor prognostic marker </plain></SENT>
<SENT sid="12" pm="."><plain>Our data also suggest that TP73 gene may play a role in colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> development </plain></SENT>
</text></document>